SEC Form 4 · accession 0001209191-16-109458
Cidara Therapeutics, Inc. · CDTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Stein
Officer — President & CEO · Director
Period of report
Mar 16, 2016
Accepted (ET)
Mar 18, 2016 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610618
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $9.89 | Mar 16, 2016 | A | 159,000 | A | — | Mar 15, 2026 | Common Stock | 159,000 | 159,000 | D |
Explanation of responses
- F1The option vests in 36 successive equal monthly installments over the three year period beginning on March 16, 2016.